USA

Shining light on the head: Photobiomodulation for brain disorders

Photobiomodulation (PBM) describes the use of red or near-infrared light to stimulate, heal, regenerate, and protect tissue that has either been injured, is degenerating, or else is at risk of dying. One of the organ systems of the human body that is most necessary to life, and whose optimum functioning is most worried about by […]

Shining light on the head: Photobiomodulation for brain disorders Read More »

Gut Feelings: The Microbiota-Gut-Brain Axis on Steroids

The intricate connection between central and enteric nervous systems is well established with emerging evidence linking gut microbiota function as a significant new contributor to gut-brain axis signaling. Several microbial signals contribute to altered gut-brain communications, with steroids representing an important biological class that impacts central and enteric nervous system function. Neuroactive steroids contribute pathologically

Gut Feelings: The Microbiota-Gut-Brain Axis on Steroids Read More »

Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview

The blood-brain barrier (BBB) is a fundamental component of the central nervous system(CNS). Its functional and structural integrity is vital to maintain the homeostasis of the brain microenvironment by controlling the passage of substances and regulating the trafficking of immune cellsbetween the blood and the brain. The BBB is primarily composed of highly specialized microvascular

Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview Read More »

A Case for Hydrogen Sulfide Metabolism as an Oxygen Sensing Mechanism

The ability to detect oxygen availability is a ubiquitous attribute of aerobic organisms. However, the mechanism(s) that transduce oxygen concentration or availability into appropriate physiological responses is less clear and often controversial. This review will make the case for oxygen-dependent metabolism of hydrogen sulfide (H2S) and polysulfides, collectively referred to as reactive sulfur species (RSS)

A Case for Hydrogen Sulfide Metabolism as an Oxygen Sensing Mechanism Read More »

The pathogenic mechanism of oral bacteria and treatment with inhibitors

Objectives: The objective of this study was to introduce the evidence obtained throughextensive research that periodontitis increases risk of many systemic diseases. Method: Analysis of some oral bacteria (P. gingivalis, T. denticola, T. forsythia, A.actinomycetemcomitans, and F. nucleatum) and its related treatments and mediatorsby the specific methods (western blot, ELISA, etc). Results: This article reviews

The pathogenic mechanism of oral bacteria and treatment with inhibitors Read More »

PROTECTIVE ROLE OF THE FLANKING DOMAINS AND MEMBRANE SELECTIVITY IN THE ALPHA-SYNUCLEIN

Alpha-synuclein protein is associated with Parkinson’s disease and is an intrinsically disordered protein (IDP) in solution. The protein consists of three domains: N-terminal domain, NAC domain, and C-terminal domain. In this research, I used the Gaussian accelerated Molecular Dynamics (GaMD) simulations to examine the role of the flanking domains of the protein. My data show

PROTECTIVE ROLE OF THE FLANKING DOMAINS AND MEMBRANE SELECTIVITY IN THE ALPHA-SYNUCLEIN Read More »

Heat Shock Protein 70 as a Sex-Skewed Regulator of α-Synucleinopathy

The role of molecular chaperones, such as heat shock protein 70 (Hsp70), is not typically studied as a function of biological sex, but by addressing this gap we might improve our understanding of proteinopathic disorders that predominate in one sex. Therefore, we exposed male or female primary hippocampal cultures to preformed α-synuclein fibrils in a

Heat Shock Protein 70 as a Sex-Skewed Regulator of α-Synucleinopathy Read More »

A New Kind of Pathogen – The prion-like pathology of amyloid fibrils in Parkinson’s disease

This chapter contrasts the prion-like behavior of alphasynuclein in Parkinson’s disease with other prion diseases.In prion diseases, the infectious, amyloid form of theprotein induces the corresponding normally folded proteinto assume the toxic fold, spreading the disease and slowlydestroying the brains of infected patients. Lewy pathologyin Parkinson’s disease appears to spread in a mannersimilar to that

A New Kind of Pathogen – The prion-like pathology of amyloid fibrils in Parkinson’s disease Read More »

Parkinson’s disease risk genes act in glia to control neuronal α-synuclein toxicity

We identified 4 modifiers: aux, Lrrk, Ric, and Vps13, orthologs of the human genes GAK, LRRK2, RIT2, and VPS13C, respectively. Knockdown of each gene exacerbated neurodegeneration as measured by total and dopaminergic neuron loss. Knockdown of each modifier also increased α-synuclein oligomerization. These results suggest that some Parkinson’s disease risk genes exert their effects in glia and that glia can influence

Parkinson’s disease risk genes act in glia to control neuronal α-synuclein toxicity Read More »